Characterization, therapeutics and control of arterial hypertension in patients of pharmacies from Vila Nova de Famalicão

Botas, Joana; Carvalhal, Daniela; Ferreira, Maria José Marinho; Pereira, Olívia R.; Pinto, Isabel C.

Publication

Characterization, therapeutics and control of arterial hypertension in patients of pharmacies from Vila Nova de Famalicão

2015Conference object

dc.contributor.author	Botas, Joana
dc.contributor.author	Carvalhal, Daniela
dc.contributor.author	Ferreira, Maria José Marinho
dc.contributor.author	Pereira, Olívia R.
dc.contributor.author	Pinto, Isabel C.
dc.date.accessioned	2016-01-08T14:23:39Z
dc.date.available	2016-01-08T14:23:39Z
dc.date.issued	2015
dc.description.abstract	Arterial Hypertension (AHT) is one of the most concerning health issues worldwide, due to its importance as a risk factor for cardiovascular diseases (CVD). Objectives: Determine the proportion of AHT, characterize the disease, therapeutics and related factors on users of 2 Pharmacies of Vila Nova de Famalicão city. Materials and Methods: It was performed a descriptive and correlational cross-sectional study included 352 users of 2 Pharmacies from Vila Nova de Famalicão. The data was collected using a questionnaire and an automatic blood pressure (BP) measuring device. Results and Discussion: The proportion of self-reported HTA was 34.4%, mostly in older age groups (66.7% and 82.4% for users with 62-72 and 84-95 years, respectively). Moreover, an important amount of hypertensive users didn’t have their BP values controlled, with values of 38% and 49% for high diastolic and high systolic BP, respectively. Concerning the pharmacological treatment, 24.8% of the hypertensive users do not take medication, most of them due to the lack of symptoms (44.2%). Diuretics were the medicines more used in AHT therapeutics (19.9%) followed by Angiotensin-Converting-Enzyme (ACE) inhibitors (14.9%), which is according to the Portuguese treatment guidelines. Some risk factors identified as associated with AHT were the age (p<0.001), Body Mass Index (BMI) (p=0.001), CVD factor history [stroke (p<0.001), heart attack (p=0.001), dyslipidemia (p<0.001), diabetes (p=0.001)] and family history of AHT (p<0.001). All of them are reported in the literature as related factors with AHT and globally as CVD. Conclusion: The AHT was more prevalent in older age groups, with high BMI and individual CVD history, being diuretics and ACE inhibitors the most used therapy.	pt_PT
dc.identifier.citation	Botas, Joana; Carvalhal, Daniela; Ferreira, Maria José Marinho; Pereira, Olívia R.; Pinto, Isabel C. (2015). Characterization, therapeutics and control of arterial hypertension in patients of pharmacies from Vila Nova de Famalicão. In II International Health Congress Gaia-Porto (II CISGP). Porto	pt_PT
dc.identifier.uri	http://hdl.handle.net/10198/12573
dc.language.iso	eng	pt_PT
dc.peerreviewed	yes	pt_PT
dc.publisher	Instituto Politécnico do Porto, Escola Superior de Tecnologia da Saúde do Porto	pt_PT
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/	pt_PT
dc.subject	Arterial hypertension	pt_PT
dc.subject	Prevalence of hypertension	pt_PT
dc.subject	Characterization of hypertension	pt_PT
dc.subject	Control of hypertension	pt_PT
dc.subject	Hypertension therapeutics	pt_PT
dc.title	Characterization, therapeutics and control of arterial hypertension in patients of pharmacies from Vila Nova de Famalicão	pt_PT
dc.type	conference object
dspace.entity.type	Publication
oaire.citation.conferencePlace	Porto	pt_PT
oaire.citation.startPage	142	pt_PT
oaire.citation.title	II International Health Congress Gaia-Porto	pt_PT
person.familyName	Pereira
person.familyName	Pinto
person.givenName	Olívia R.
person.givenName	Isabel C.
person.identifier	145216
person.identifier.ciencia-id	B312-AF21-D2FA
person.identifier.ciencia-id	851B-247F-C650
person.identifier.orcid	0000-0002-6275-3134
person.identifier.orcid	0000-0003-4745-6489
person.identifier.rid	H-1049-2014
person.identifier.scopus-author-id	52264387000
rcaap.rights	openAccess	pt_PT
rcaap.type	conferenceObject	pt_PT
relation.isAuthorOfPublication	e8fdab9a-3ad6-47e6-b90c-7a37aabcb453
relation.isAuthorOfPublication	751d74ab-e27c-4713-97ba-62cad38d1890
relation.isAuthorOfPublication.latestForDiscovery	751d74ab-e27c-4713-97ba-62cad38d1890